spacer
spacer

PDBsum entry 1h8f

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Kinase PDB id
1h8f

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
352 a.a. *
Ligands
EPE ×2
Waters ×161
* Residue conservation analysis
PDB id:
1h8f
Name: Kinase
Title: Glycogen synthase kinase 3 beta.
Structure: Glycogen synthase kinase-3 beta. Chain: a, b. Synonym: gsk3b. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf9.
Biol. unit: Dimer (from PQS)
Resolution:
2.80Å     R-factor:   0.220     R-free:   0.256
Authors: R.Dajani,L.H.Pearl,S.M.Roe
Key ref:
R.Dajani et al. (2001). Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition. Cell, 105, 721-732. PubMed id: 11440715 DOI: 10.1016/S0092-8674(01)00374-9
Date:
05-Feb-01     Release date:   31-Jan-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P49841  (GSK3B_HUMAN) -  Glycogen synthase kinase-3 beta from Homo sapiens
Seq:
Struc:
420 a.a.
352 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 3 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class 1: E.C.2.7.11.1  - non-specific serine/threonine protein kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
2. L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
L-seryl-[protein]
+ ATP
= O-phospho-L-seryl-[protein]
+ ADP
+ H(+)
L-threonyl-[protein]
+ ATP
= O-phospho-L-threonyl-[protein]
+ ADP
+ H(+)
   Enzyme class 2: E.C.2.7.11.26  - [tau protein] kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction:
1. L-seryl-[tau protein] + ATP = O-phospho-L-seryl-[tau protein] + ADP + H+
2. L-threonyl-[tau protein] + ATP = O-phospho-L-threonyl-[tau protein] + ADP + H+
L-seryl-[tau protein]
+ ATP
= O-phospho-L-seryl-[tau protein]
+ ADP
+ H(+)
L-threonyl-[tau protein]
+ ATP
= O-phospho-L-threonyl-[tau protein]
+ ADP
+ H(+)
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    reference    
 
 
DOI no: 10.1016/S0092-8674(01)00374-9 Cell 105:721-732 (2001)
PubMed id: 11440715  
 
 
Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition.
R.Dajani, E.Fraser, S.M.Roe, N.Young, V.Good, T.C.Dale, L.H.Pearl.
 
  ABSTRACT  
 
Glycogen synthase kinase 3 beta (GSK3 beta) plays a key role in insulin and Wnt signaling, phosphorylating downstream targets by default, and becoming inhibited following the extracellular signaling event. The crystal structure of human GSK3 beta shows a catalytically active conformation in the absence of activation-segment phosphorylation, with the sulphonate of a buffer molecule bridging the activation-segment and N-terminal domain in the same way as the phosphate group of the activation-segment phospho-Ser/Thr in other kinases. The location of this oxyanion binding site in the substrate binding cleft indicates direct coupling of P+4 phosphate-primed substrate binding and catalytic activation, explains the ability of GSK3 beta to processively hyperphosphorylate substrates with Ser/Thr pentad-repeats, and suggests a mechanism for autoinhibition in which the phosphorylated N terminus binds as a competitive pseudosubstrate with phospho-Ser 9 occupying the P+4 site.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. Structure of Human GSK3β(A) Stereo pair secondary structure cartoon of human glycogen synthase kinase 3β colored blue-red from the visible N terminus at residue 35 to the visible C terminus at residue 384. The orthogonal β barrel formed by the N-terminal domain is on the left. All molecular graphics were generated using Robert Esnouf's adaptation (Bobscript) of Molscript (Kraulis, 1991) and Raster3D (Merrit and Murphy, 1994), except for Figure 3 and Figure 6, which were generated with GRASP (Nicholls et al., 1993).(B) As (A), but with the view rotated by 90° around the horizontal
Figure 4.
Figure 4. Phospho-Substrate Binding Model and Tyr 216 Conformation(A) Model of substrate binding to GSK3β based on structural alignment with the structure of a phosphorylase kinase–peptide substrate complex (PDB code 2PHK). The modeled substrate corresponds to residues 642–648 of human glycogen synthase (-642-PPSPSLS-648), whose phosphorylation at Ser 644 by GSK3β requires a “priming” phosphoserine at 648. The position of the serine to be phosphorylated is indicated at P(0) and that of the priming phospho-serine at P(+4). The phosphate at P(+4) occupies the same position as the sulphonate of the bound HEPES. The rotamer of Tyr 216 was changed to an anti conformation to eliminate steric clashes.(B) Comparison of the conformations of the activation segment tyrosine in GSK3β (left) and the phosphorylated equivalent tyrosine in activated ERK2. Simple rotation of the side chain of Tyr 216 in GSK3β around the Cα-Cβ bond brings it into the same position as the pTyr 185 in ERK2, and, if phosphorylated, would be stabilized in that conformation by interaction with Arg 220 and Arg 223
 
  The above figures are reprinted by permission from Cell Press: Cell (2001, 105, 721-732) copyright 2001.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22278060 M.A.Israel, S.H.Yuan, C.Bardy, S.M.Reyna, Y.Mu, C.Herrera, M.P.Hefferan, S.Van Gorp, K.L.Nazor, F.S.Boscolo, C.T.Carson, L.C.Laurent, M.Marsala, F.H.Gage, A.M.Remes, E.H.Koo, and L.S.Goldstein (2012).
Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
  Nature, 482, 216-220.  
21354422 A.Licht-Murava, B.Plotkin, M.Eisenstein, and H.Eldar-Finkelman (2011).
Elucidating substrate and inhibitor binding sites on the surface of GSK-3β and the refinement of a competitive inhibitor.
  J Mol Biol, 408, 366-378.  
21270887 D.Y.Chen, S.A.Stern, A.Garcia-Osta, B.Saunier-Rebori, G.Pollonini, D.Bambah-Mukku, R.D.Blitzer, and C.M.Alberini (2011).
A critical role for IGF-II in memory consolidation and enhancement.
  Nature, 469, 491-497.  
20473698 H.Sun, Y.J.Jiang, Q.S.Yu, C.C.Luo, and J.W.Zou (2011).
The effect of Li(+) on GSK-3 inhibition: Molecular dynamics simulation.
  J Mol Model, 17, 377-381.  
21443429 J.L.Johnson, S.G.Rupasinghe, F.Stefani, M.A.Schuler, and E.Gonzalez de Mejia (2011).
Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity.
  J Med Food, 14, 325-333.  
21212533 K.Saeki, M.Machida, Y.Kinoshita, R.Takasawa, and S.Tanuma (2011).
Glycogen synthase kinase-3β2 has lower phosphorylation activity to tau than glycogen synthase kinase-3β1.
  Biol Pharm Bull, 34, 146-149.  
21244636 N.Zhang, R.Zhong, H.Yan, and Y.Jiang (2011).
Structural features underlying selective inhibition of GSK3β by dibromocantharelline: implications for rational drug design.
  Chem Biol Drug Des, 77, 199-205.  
21261990 V.M.Campa, and R.M.Kypta (2011).
Issues associated with the use of phosphospecific antibodies to localise active and inactive pools of GSK-3 in cells.
  Biol Direct, 6, 4.  
21126318 W.Becker, and W.Sippl (2011).
Activation, regulation, and inhibition of DYRK1A.
  FEBS J, 278, 246-256.  
  21328310 X.N.Tang, C.W.Lo, Y.C.Chuang, C.T.Chen, Y.C.Sun, Y.R.Hong, and C.N.Yang (2011).
Prediction of the binding mode between GSK3β and a peptide derived from GSKIP using molecular dynamics simulation.
  Biopolymers, 95, 461-471.  
20018914 A.K.Ghosh, C.R.Secreto, T.R.Knox, W.Ding, D.Mukhopadhyay, and N.E.Kay (2010).
Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression.
  Blood, 115, 1755-1764.  
20648061 E.M.Hur, and F.Q.Zhou (2010).
GSK3 signalling in neural development.
  Nat Rev Neurosci, 11, 539-551.  
20352103 F.De Toni-Costes, M.Despeaux, J.Bertrand, E.Bourogaa, L.Ysebaert, B.Payrastre, and C.Racaud-Sultan (2010).
A New alpha5beta1 integrin-dependent survival pathway through GSK3beta activation in leukemic cells.
  PLoS One, 5, e9807.  
20670375 G.Marwarha, B.Dasari, J.P.Prabhakara, J.Schommer, and O.Ghribi (2010).
β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway.
  J Neurochem, 115, 373-384.  
20713710 H.Fan-Minogue, Z.Cao, R.Paulmurugan, C.T.Chan, T.F.Massoud, D.W.Felsher, and S.S.Gambhir (2010).
Noninvasive molecular imaging of c-Myc activation in living mice.
  Proc Natl Acad Sci U S A, 107, 15892-15897.  
21105670 I.Buch, D.Fishelovitch, N.London, B.Raveh, H.J.Wolfson, and R.Nussinov (2010).
Allosteric regulation of glycogen synthase kinase 3β: a theoretical study.
  Biochemistry, 49, 10890-10901.  
20420491 J.Avila, F.Wandosell, and F.Hernández (2010).
Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors.
  Expert Rev Neurother, 10, 703-710.  
20080974 J.L.Buescher, and C.J.Phiel (2010).
A noncatalytic domain of glycogen synthase kinase-3 (GSK-3) is essential for activity.
  J Biol Chem, 285, 7957-7963.  
20017491 J.Peng, S.Kudrimoti, S.Prasanna, S.Odde, R.J.Doerksen, H.K.Pennaka, Y.M.Choo, K.V.Rao, B.L.Tekwani, V.Madgula, S.I.Khan, B.Wang, A.M.Mayer, M.R.Jacob, L.C.Tu, J.Gertsch, and M.T.Hamann (2010).
Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections.
  J Med Chem, 53, 61-76.  
20568963 L.J.Chen, Y.J.Wang, and G.F.Tseng (2010).
Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons.
  J Neurotrauma, 27, 1657-1669.  
  20631880 R.Ko, H.D.Jang, and S.Y.Lee (2010).
GSK3beta Inhibitor Peptide Protects Mice from LPS-induced Endotoxin Shock.
  Immune Netw, 10, 99.  
20537194 R.Mishra (2010).
Glycogen synthase kinase 3 beta: can it be a target for oral cancer.
  Mol Cancer, 9, 144.  
20043192 S.L.Howng, C.C.Hwang, C.Y.Hsu, M.Y.Hsu, C.Y.Teng, C.H.Chou, M.F.Lee, C.H.Wu, S.J.Chiou, A.S.Lieu, J.K.Loh, C.N.Yang, C.S.Lin, and Y.R.Hong (2010).
Involvement of the residues of GSKIP, AxinGID, and FRATtide in their binding with GSK3beta to unravel a novel C-terminal scaffold-binding region.
  Mol Cell Biochem, 339, 23-33.  
19712106 A.Stein, R.A.Pache, P.Bernadó, M.Pons, and P.Aloy (2009).
Dynamic interactions of proteins in complex networks: a more structured view.
  FEBS J, 276, 5390-5405.  
19366350 G.V.Rayasam, V.K.Tulasi, R.Sodhi, J.A.Davis, and A.Ray (2009).
Glycogen synthase kinase 3: more than a namesake.
  Br J Pharmacol, 156, 885-898.  
19633101 J.C.Braz, R.M.Gill, A.K.Corbly, B.D.Jones, N.Jin, C.J.Vlahos, Q.Wu, and W.Shen (2009).
Selective activation of PI3K{alpha}/Akt/GSK-3{beta} signalling and cardiac compensatory hypertrophy during recovery from heart failure.
  Eur J Heart Fail, 11, 739-748.  
19440740 K.H.Kim, I.Gaisina, F.Gallier, D.Holzle, S.Y.Blond, A.Mesecar, and A.P.Kozikowski (2009).
Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitors.
  J Mol Model, 15, 1463-1479.  
19364825 M.Galletti, S.Riccardo, F.Parisi, C.Lora, M.K.Saqcena, L.Rivas, B.Wong, A.Serra, F.Serras, D.Grifoni, P.Pelicci, J.Jiang, and P.Bellosta (2009).
Identification of domains responsible for ubiquitin-dependent degradation of dMyc by glycogen synthase kinase 3beta and casein kinase 1 kinases.
  Mol Cell Biol, 29, 3424-3434.  
19003984 N.Zhang, Y.Jiang, J.Zou, Q.Yu, and W.Zhao (2009).
Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.
  Proteins, 75, 671-681.  
19006085 P.Goñi-Oliver, J.Avila, and F.Hernández (2009).
Calpain-mediated truncation of GSK-3 in post-mortem brain samples.
  J Neurosci Res, 87, 1156-1161.  
19390045 Q.A.Justman, Z.Serber, J.E.Ferrell, H.El-Samad, and K.M.Shokat (2009).
Tuning the activation threshold of a kinase network by nested feedback loops.
  Science, 324, 509-512.  
19066717 S.I.Yun, H.Y.Yoon, S.Y.Jeong, and Y.S.Chung (2009).
Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta.
  J Bone Miner Metab, 27, 140-148.  
19497850 S.Umar, S.Sarkar, Y.Wang, and P.Singh (2009).
Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin.
  J Biol Chem, 284, 22274-22284.  
18851699 A.Kannoji, S.Phukan, V.Sudher Babu, and V.N.Balaji (2008).
GSK3beta: a master switch and a promising target.
  Expert Opin Ther Targets, 12, 1443-1455.  
18184370 D.Muyllaert, A.Kremer, T.Jaworski, P.Borghgraef, H.Devijver, S.Croes, I.Dewachter, and F.Van Leuven (2008).
Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
  Genes Brain Behav, 7, 57-66.  
18342599 D.Y.Mao, D.F.Ceccarelli, and F.Sicheri (2008).
"Unraveling the tail" of how SRPK1 phosphorylates ASF/SF2.
  Mol Cell, 29, 535-537.  
18687337 J.C.Hagopian, C.T.Ma, B.R.Meade, C.P.Albuquerque, J.C.Ngo, G.Ghosh, P.A.Jennings, X.D.Fu, and J.A.Adams (2008).
Adaptable molecular interactions guide phosphorylation of the SR protein ASF/SF2 by SRPK1.
  J Mol Biol, 382, 894-909.  
18342604 J.C.Ngo, K.Giang, S.Chakrabarti, C.T.Ma, N.Huynh, J.C.Hagopian, P.C.Dorrestein, X.D.Fu, J.A.Adams, and G.Ghosh (2008).
A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1.
  Mol Cell, 29, 563-576.
PDB code: 3beg
18644955 K.K.Ojo, J.R.Gillespie, A.J.Riechers, A.J.Napuli, C.L.Verlinde, F.S.Buckner, M.H.Gelb, M.M.Domostoj, S.J.Wells, A.Scheer, T.N.Wells, and W.C.Van Voorhis (2008).
Glycogen synthase kinase 3 is a potential drug target for African trypanosomiasis therapy.
  Antimicrob Agents Chemother, 52, 3710-3717.  
18987186 K.N.Green, J.S.Steffan, H.Martinez-Coria, X.Sun, S.S.Schreiber, L.M.Thompson, and F.M.LaFerla (2008).
Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau.
  J Neurosci, 28, 11500-11510.  
18816110 K.Vougogiannopoulou, Y.Ferandin, K.Bettayeb, V.Myrianthopoulos, O.Lozach, Y.Fan, C.H.Johnson, P.Magiatis, A.L.Skaltsounis, E.Mikros, and L.Meijer (2008).
Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.
  J Med Chem, 51, 6421-6431.  
17902168 M.H.Ni, C.C.Wu, W.H.Chan, K.Y.Chien, and J.S.Yu (2008).
GSK-3 mediates the okadaic acid-induced modification of collapsin response mediator protein-2 in human SK-N-SH neuroblastoma cells.
  J Cell Biochem, 103, 1833-1848.  
18407748 M.Thirunavukkarasu, Z.Han, L.Zhan, S.V.Penumathsa, V.P.Menon, and N.Maulik (2008).
Adeno-sh-beta-catenin abolishes ischemic preconditioning-mediated cardioprotection by downregulation of its target genes VEGF, Bcl-2, and survivin in ischemic rat myocardium.
  Antioxid Redox Signal, 10, 1475-1484.  
18204489 P.H.Sugden, S.J.Fuller, S.C.Weiss, and A.Clerk (2008).
Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.
  Br J Pharmacol, 153, S137-S153.  
  18726001 P.Peng, Z.Yan, Y.Zhu, and J.Li (2008).
Regulation of the Arabidopsis GSK3-like Kinase BRASSINOSTEROID-INSENSITIVE 2 through Proteasome-Mediated Protein Degradation.
  Mol Plant, 1, 338-346.  
19107203 S.Piao, S.H.Lee, H.Kim, S.Yum, J.L.Stamos, Y.Xu, S.J.Lee, J.Lee, S.Oh, J.K.Han, B.J.Park, W.I.Weis, and N.C.Ha (2008).
Direct inhibition of GSK3beta by the phosphorylated cytoplasmic domain of LRP6 in Wnt/beta-catenin signaling.
  PLoS ONE, 3, e4046.  
18202849 T.Adell, M.Marsal, and E.Saló (2008).
Planarian GSK3s are involved in neural regeneration.
  Dev Genes Evol, 218, 89.  
18451303 T.M.Thornton, G.Pedraza-Alva, B.Deng, C.D.Wood, A.Aronshtam, J.L.Clements, G.Sabio, R.J.Davis, D.E.Matthews, B.Doble, and M.Rincon (2008).
Phosphorylation by p38 MAPK as an alternative pathway for GSK3beta inactivation.
  Science, 320, 667-670.  
18195042 V.Hongisto, J.C.Vainio, R.Thompson, M.J.Courtney, and E.T.Coffey (2008).
The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
  Mol Cell Biol, 28, 1515-1527.  
17355201 A.Baki, A.Bielik, L.Molnár, G.Szendrei, and G.M.Keserü (2007).
A high throughput luminescent assay for glycogen synthase kinase-3beta inhibitors.
  Assay Drug Dev Technol, 5, 75-83.  
17544131 A.R.Cole, A.Astell, C.Green, and C.Sutherland (2007).
Molecular connexions between dementia and diabetes.
  Neurosci Biobehav Rev, 31, 1046-1063.  
17427040 G.Claisse, B.Charrier, and M.Kreis (2007).
The Arabidopsis thaliana GSK3/Shaggy like kinase AtSK3-2 modulates floral cell expansion.
  Plant Mol Biol, 64, 113-124.  
17438332 G.P.Meares, and R.S.Jope (2007).
Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis.
  J Biol Chem, 282, 16989-17001.  
17391014 H.Xie, S.Vucetic, L.M.Iakoucheva, C.J.Oldfield, A.K.Dunker, V.N.Uversky, and Z.Obradovic (2007).
Functional anthology of intrinsic disorder. 1. Biological processes and functions of proteins with long disordered regions.
  J Proteome Res, 6, 1882-1898.  
17585314 J.A.Ubersax, and J.E.Ferrell (2007).
Mechanisms of specificity in protein phosphorylation.
  Nat Rev Mol Cell Biol, 8, 530-541.  
17997701 J.Avila, and F.Hernández (2007).
GSK-3 inhibitors for Alzheimer's disease.
  Expert Rev Neurother, 7, 1527-1533.  
17224784 L.Dugo, M.Collin, and C.Thiemermann (2007).
Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation.
  Shock, 27, 113-123.  
17085634 L.Strmecki, G.Bloomfield, T.Araki, E.Dalton, J.Skelton, C.Schilde, A.Harwood, J.G.Williams, A.Ivens, and C.Pears (2007).
Proteomic and microarray analyses of the Dictyostelium Zak1-GSK-3 signaling pathway reveal a role in early development.
  Eukaryot Cell, 6, 245-252.  
17499358 M.K.Rowe, C.Wiest, and D.M.Chuang (2007).
GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder.
  Neurosci Biobehav Rev, 31, 920-931.  
17179144 M.Wrzaczek, W.Rozhon, and C.Jonak (2007).
A Proteasome-regulated glycogen synthase kinase-3 modulates disease response in plants.
  J Biol Chem, 282, 5249-5255.  
17569662 P.Goñi-Oliver, J.J.Lucas, J.Avila, and F.Hernández (2007).
N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation.
  J Biol Chem, 282, 22406-22413.  
17644338 P.Patwardhan, and W.T.Miller (2007).
Processive phosphorylation: mechanism and biological importance.
  Cell Signal, 19, 2218-2226.  
17179138 R.Kalamegham, D.Sturgill, E.Siegfried, and B.Oliver (2007).
Drosophila mojoless, a retroposed GSK-3, has functionally diverged to acquire an essential role in male fertility.
  Mol Biol Evol, 24, 732-742.  
17229088 A.A.Asuni, C.Hooper, C.H.Reynolds, S.Lovestone, B.H.Anderton, and R.Killick (2006).
GSK3alpha exhibits beta-catenin and tau directed kinase activities that are modulated by Wnt.
  Eur J Neurosci, 24, 3387-3392.  
17079133 A.Reményi, M.C.Good, and W.A.Lim (2006).
Docking interactions in protein kinase and phosphatase networks.
  Curr Opin Struct Biol, 16, 676-685.  
16794575 A.W.Oliver, A.Paul, K.J.Boxall, S.E.Barrie, G.W.Aherne, M.D.Garrett, S.Mittnacht, and L.H.Pearl (2006).
Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange.
  EMBO J, 25, 3179-3190.
PDB codes: 2cn5 2cn8
16452634 C.L.Sayas, A.Ariaens, B.Ponsioen, and W.H.Moolenaar (2006).
GSK-3 is activated by the tyrosine kinase Pyk2 during LPA1-mediated neurite retraction.
  Mol Biol Cell, 17, 1834-1844.  
16803897 F.Plattner, M.Angelo, and K.P.Giese (2006).
The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
  J Biol Chem, 281, 25457-25465.  
17110931 M.Engel, V.Hindie, L.A.Lopez-Garcia, A.Stroba, F.Schaeffer, I.Adrian, J.Imig, L.Idrissova, W.Nastainczyk, S.Zeuzem, P.M.Alzari, R.W.Hartmann, A.Piiper, and R.M.Biondi (2006).
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds.
  EMBO J, 25, 5469-5480.  
16790421 M.K.Ayrapetov, Y.H.Wang, X.Lin, X.Gu, K.Parang, and G.Sun (2006).
Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
  J Biol Chem, 281, 23776-23784.  
16862553 O.Hernández-Hernández, M.Bermúdez-de-León, P.Gómez, P.Velázquez-Bernardino, F.García-Sierra, and B.Cisneros (2006).
Myotonic dystrophy expanded CUG repeats disturb the expression and phosphorylation of tau in PC12 cells.
  J Neurosci Res, 84, 841-851.  
17188038 P.A.Lochhead, R.Kinstrie, G.Sibbet, T.Rawjee, N.Morrice, and V.Cleghon (2006).
A chaperone-dependent GSK3beta transitional intermediate mediates activation-loop autophosphorylation.
  Mol Cell, 24, 627-633.  
16464655 P.De Sarno, G.N.Bijur, A.A.Zmijewska, X.Li, and R.S.Jope (2006).
In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors.
  Neurobiol Aging, 27, 413-422.  
16893889 R.Ilouz, N.Kowalsman, M.Eisenstein, and H.Eldar-Finkelman (2006).
Identification of novel glycogen synthase kinase-3beta substrate-interacting residues suggests a common mechanism for substrate recognition.
  J Biol Chem, 281, 30621-30630.  
16756506 R.P.Bhattacharyya, A.Reményi, B.J.Yeh, and W.A.Lim (2006).
Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits.
  Annu Rev Biochem, 75, 655-680.  
16732330 S.Benzeno, F.Lu, M.Guo, O.Barbash, F.Zhang, J.G.Herman, P.S.Klein, A.Rustgi, and J.A.Diehl (2006).
Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.
  Oncogene, 25, 6291-6303.  
16706678 T.D.Gould (2006).
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications.
  Expert Opin Ther Targets, 10, 377-392.  
16982607 T.Hagen, D.A.Cross, A.A.Culbert, A.West, S.Frame, N.Morrice, and A.D.Reith (2006).
FRAT1, a substrate-specific regulator of glycogen synthase kinase-3 activity, is a cellular substrate of protein kinase A.
  J Biol Chem, 281, 35021-35029.  
16505477 Y.Liu, N.V.Belkina, C.Graham, and S.Shaw (2006).
Independence of protein kinase C-delta activity from activation loop phosphorylation: structural basis and altered functions in cells.
  J Biol Chem, 281, 12102-12111.  
16218947 A.K.Dunker, M.S.Cortese, P.Romero, L.M.Iakoucheva, and V.N.Uversky (2005).
Flexible nets. The roles of intrinsic disorder in protein interaction networks.
  FEBS J, 272, 5129-5148.  
16185152 B.Fiedler, and K.C.Wollert (2005).
Targeting calcineurin and associated pathways in cardiac hypertrophy and failure.
  Expert Opin Ther Targets, 9, 963-973.  
15741170 D.Komander, G.Kular, M.Deak, D.R.Alessi, and D.M.van Aalten (2005).
Role of T-loop phosphorylation in PDK1 activation, stability, and substrate binding.
  J Biol Chem, 280, 18797-18802.
PDB code: 2biy
16014608 D.Matenia, B.Griesshaber, X.Y.Li, A.Thiessen, C.Johne, J.Jiao, E.Mandelkow, and E.M.Mandelkow (2005).
PAK5 kinase is an inhibitor of MARK/Par-1, which leads to stable microtubules and dynamic actin.
  Mol Biol Cell, 16, 4410-4422.  
16275766 E.S.Hwang, J.H.Hong, and L.H.Glimcher (2005).
IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508.
  J Exp Med, 202, 1289-1300.  
15537647 E.Smith, and B.Frenkel (2005).
Glucocorticoids inhibit the transcriptional activity of LEF/TCF in differentiating osteoblasts in a glycogen synthase kinase-3beta-dependent and -independent manner.
  J Biol Chem, 280, 2388-2394.  
16277616 F.Liu, X.Gong, G.Zhang, K.Marquis, P.Reinhart, and T.H.Andree (2005).
The inhibition of glycogen synthase kinase 3beta by a metabotropic glutamate receptor 5 mediated pathway confers neuroprotection to Abeta peptides.
  J Neurochem, 95, 1363-1372.  
15780591 J.R.Woodgett (2005).
Recent advances in the protein kinase B signaling pathway.
  Curr Opin Cell Biol, 17, 150-157.  
15837931 M.Yang, W.W.Zhong, N.Srivastava, A.Slavin, J.Yang, T.Hoey, and S.An (2005).
G protein-coupled lysophosphatidic acid receptors stimulate proliferation of colon cancer cells through the {beta}-catenin pathway.
  Proc Natl Acad Sci U S A, 102, 6027-6032.  
15827567 T.D.Gould, and H.K.Manji (2005).
Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs.
  Neuropsychopharmacology, 30, 1223-1237.  
16094605 V.N.Uversky, C.J.Oldfield, and A.K.Dunker (2005).
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling.
  J Mol Recognit, 18, 343-384.  
  15522877 W.H.Stoothoff, J.H.Cho, R.P.McDonald, and G.V.Johnson (2005).
FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation.
  J Biol Chem, 280, 270-276.  
16341017 X.Zeng, K.Tamai, B.Doble, S.Li, H.Huang, R.Habas, H.Okamura, J.Woodgett, and X.He (2005).
A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
  Nature, 438, 873-877.  
15020584 A.Michael, S.Haq, X.Chen, E.Hsich, L.Cui, B.Walters, Z.Shao, K.Bhattacharya, H.Kilter, G.Huggins, M.Andreucci, M.Periasamy, R.N.Solomon, R.Liao, R.Patten, J.D.Molkentin, and T.Force (2004).
Glycogen synthase kinase-3beta regulates growth, calcium homeostasis, and diastolic function in the heart.
  J Biol Chem, 279, 21383-21393.  
14593110 A.V.Skurat, and A.D.Dietrich (2004).
Phosphorylation of Ser640 in muscle glycogen synthase by DYRK family protein kinases.
  J Biol Chem, 279, 2490-2498.  
15143183 D.Papadopoulou, M.W.Bianchi, and M.Bourouis (2004).
Functional studies of shaggy/glycogen synthase kinase 3 phosphorylation sites in Drosophila melanogaster.
  Mol Cell Biol, 24, 4909-4919.  
14966281 H.Matsubayashi, S.Sese, J.S.Lee, T.Shirakawa, T.Iwatsubo, T.Tomita, and S.Yanagawa (2004).
Biochemical characterization of the Drosophila wingless signaling pathway based on RNA interference.
  Mol Cell Biol, 24, 2012-2024.  
15282298 I.Rubin-Bejerano, S.Sagee, O.Friedman, L.Pnueli, and Y.Kassir (2004).
The in vivo activity of Ime1, the key transcriptional activator of meiosis-specific genes in Saccharomyces cerevisiae, is inhibited by the cyclic AMP/protein kinase A signal pathway through the glycogen synthase kinase 3-beta homolog Rim11.
  Mol Cell Biol, 24, 6967-6979.  
15456871 L.Litovchick, A.Chestukhin, and J.A.DeCaprio (2004).
Glycogen synthase kinase 3 phosphorylates RBL2/p130 during quiescence.
  Mol Cell Biol, 24, 8970-8980.  
14993667 M.Aoki, T.Yokota, I.Sugiura, C.Sasaki, T.Hasegawa, C.Okumura, K.Ishiguro, T.Kohno, S.Sugio, and T.Matsuzaki (2004).
Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta.
  Acta Crystallogr D Biol Crystallogr, 60, 439-446.
PDB codes: 1j1b 1j1c
  15173880 M.Juhaszova, D.B.Zorov, S.H.Kim, S.Pepe, Q.Fu, K.W.Fishbein, B.D.Ziman, S.Wang, K.Ytrehus, C.L.Antos, E.N.Olson, and S.J.Sollott (2004).
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore.
  J Clin Invest, 113, 1535-1549.  
15470259 N.F.Wilson, and P.A.Lefebvre (2004).
Regulation of flagellar assembly by glycogen synthase kinase 3 in Chlamydomonas reinhardtii.
  Eukaryot Cell, 3, 1307-1319.  
15273306 N.Kannan, and A.F.Neuwald (2004).
Evolutionary constraints associated with functional specificity of the CMGC protein kinases MAPK, CDK, GSK, SRPK, DYRK, and CK2alpha.
  Protein Sci, 13, 2059-2077.  
15173837 P.Cohen, and M.Goedert (2004).
GSK3 inhibitors: development and therapeutic potential.
  Nat Rev Drug Discov, 3, 479-487.  
14769788 P.H.Tartaix, M.Doulaverakis, A.George, L.W.Fisher, W.T.Butler, C.Qin, E.Salih, M.Tan, Y.Fujimoto, L.Spevak, and A.L.Boskey (2004).
In vitro effects of dentin matrix protein-1 on hydroxyapatite formation provide insights into in vivo functions.
  J Biol Chem, 279, 18115-18120.  
15073180 R.van Amerongen, H.van der Gulden, F.Bleeker, J.Jonkers, and A.Berns (2004).
Characterization and functional analysis of the murine Frat2 gene.
  J Biol Chem, 279, 26967-26974.  
14985354 T.R.Salas, J.Kim, F.Vakar-Lopez, A.L.Sabichi, P.Troncoso, G.Jenster, A.Kikuchi, S.Y.Chen, L.Shemshedini, M.Suraokar, C.J.Logothetis, J.DiGiovanni, S.M.Lippman, and D.G.Menter (2004).
Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity.
  J Biol Chem, 279, 19191-19200.  
15073173 Z.Yuan, A.Agarwal-Mawal, and H.K.Paudel (2004).
14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain.
  J Biol Chem, 279, 26105-26114.  
12551948 A.Agarwal-Mawal, H.Y.Qureshi, P.W.Cafferty, Z.Yuan, D.Han, R.Lin, and H.K.Paudel (2003).
14-3-3 connects glycogen synthase kinase-3 beta to tau within a brain microtubule-associated tau phosphorylation complex.
  J Biol Chem, 278, 12722-12728.  
12509752 A.Pires-daSilva, and R.J.Sommer (2003).
The evolution of signalling pathways in animal development.
  Nat Rev Genet, 4, 39-49.  
12615961 B.W.Doble, and J.R.Woodgett (2003).
GSK-3: tricks of the trade for a multi-tasking kinase.
  J Cell Sci, 116, 1175-1186.  
12796505 F.Zhang, C.J.Phiel, L.Spece, N.Gurvich, and P.S.Klein (2003).
Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3.
  J Biol Chem, 278, 33067-33077.  
12409305 J.H.Cho, and G.V.Johnson (2003).
Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding.
  J Biol Chem, 278, 187-193.  
14690613 K.Stankunas, J.H.Bayle, J.E.Gestwicki, Y.M.Lin, T.J.Wandless, and G.R.Crabtree (2003).
Conditional protein alleles using knockin mice and a chemical inducer of dimerization.
  Mol Cell, 12, 1615-1624.  
14700633 L.Meijer, A.L.Skaltsounis, P.Magiatis, P.Polychronopoulos, M.Knockaert, M.Leost, X.P.Ryan, C.A.Vonica, A.Brivanlou, R.Dajani, C.Crovace, C.Tarricone, A.Musacchio, S.M.Roe, L.Pearl, and P.Greengard (2003).
GSK-3-selective inhibitors derived from Tyrian purple indirubins.
  Chem Biol, 10, 1255-1266.
PDB code: 1uv5
14563837 M.A.Gregory, Y.Qi, and S.R.Hann (2003).
Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization.
  J Biol Chem, 278, 51606-51612.  
14536078 M.Welcker, J.Singer, K.R.Loeb, J.Grim, A.Bloecher, M.Gurien-West, B.E.Clurman, and J.M.Roberts (2003).
Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation.
  Mol Cell, 12, 381-392.  
12925738 O.Marin, V.H.Bustos, L.Cesaro, F.Meggio, M.A.Pagano, M.Antonelli, C.C.Allende, L.A.Pinna, and J.E.Allende (2003).
A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteins.
  Proc Natl Acad Sci U S A, 100, 10193-10200.  
12697809 P.M.Chan, S.Ilangumaran, J.La Rose, A.Chakrabartty, and R.Rottapel (2003).
Autoinhibition of the kit receptor tyrosine kinase by the cytosolic juxtamembrane region.
  Mol Cell Biol, 23, 3067-3078.  
12624102 P.Rudrabhatla, and R.Rajasekharan (2003).
Mutational analysis of stress-responsive peanut dual specificity protein kinase. Identification of tyrosine residues involved in regulation of protein kinase activity.
  J Biol Chem, 278, 17328-17335.  
14523002 P.Watcharasit, G.N.Bijur, L.Song, J.Zhu, X.Chen, and R.S.Jope (2003).
Glycogen synthase kinase-3beta (GSK3beta) binds to and promotes the actions of p53.
  J Biol Chem, 278, 48872-48879.  
12554650 R.Dajani, E.Fraser, S.M.Roe, M.Yeo, V.M.Good, V.Thompson, T.C.Dale, and L.H.Pearl (2003).
Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
  EMBO J, 22, 494-501.
PDB code: 1o9u
12668767 S.Haq, A.Michael, M.Andreucci, K.Bhattacharya, P.Dotto, B.Walters, J.Woodgett, H.Kilter, and T.Force (2003).
Stabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth.
  Proc Natl Acad Sci U S A, 100, 4610-4615.  
  12937146 T.Ishizawa, N.Sahara, K.Ishiguro, J.Kersh, E.McGowan, J.Lewis, M.Hutton, D.W.Dickson, and S.H.Yen (2003).
Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
  Am J Pathol, 163, 1057-1067.  
12900420 T.R.Salas, S.A.Reddy, J.L.Clifford, R.J.Davis, A.Kikuchi, S.M.Lippman, and D.G.Menter (2003).
Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
  J Biol Chem, 278, 41338-41346.  
12588975 X.Wang, W.Li, J.L.Parra, A.Beugnet, and C.G.Proud (2003).
The C terminus of initiation factor 4E-binding protein 1 contains multiple regulatory features that influence its function and phosphorylation.
  Mol Cell Biol, 23, 1546-1557.  
12111750 A.Martinez, A.Castro, I.Dorronsoro, and M.Alonso (2002).
Glycogen synthase kinase 3 (GSK-3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation.
  Med Res Rev, 22, 373-384.  
11956225 B.J.Eickholt, F.S.Walsh, and P.Doherty (2002).
An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling.
  J Cell Biol, 157, 211-217.  
12399181 C.Jonak, and H.Hirt (2002).
Glycogen synthase kinase 3/SHAGGY-like kinases in plants: an emerging family with novel functions.
  Trends Plant Sci, 7, 457-461.  
11782539 C.L.Antos, T.A.McKinsey, N.Frey, W.Kutschke, J.McAnally, J.M.Shelton, J.A.Richardson, J.A.Hill, and E.N.Olson (2002).
Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo.
  Proc Natl Acad Sci U S A, 99, 907-912.  
11955436 C.Liu, Y.Li, M.Semenov, C.Han, G.H.Baeg, Y.Tan, Z.Zhang, X.Lin, and X.He (2002).
Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism.
  Cell, 108, 837-847.  
12351631 C.M.Sheridan, E.K.Heist, C.R.Beals, G.R.Crabtree, and P.Gardner (2002).
Protein kinase A negatively modulates the nuclear accumulation of NF-ATc1 by priming for subsequent phosphorylation by glycogen synthase kinase-3.
  J Biol Chem, 277, 48664-48676.  
12147701 C.Tanji, H.Yamamoto, N.Yorioka, N.Kohno, K.Kikuchi, and A.Kikuchi (2002).
A-kinase anchoring protein AKAP220 binds to glycogen synthase kinase-3beta (GSK-3beta ) and mediates protein kinase A-dependent inhibition of GSK-3beta.
  J Biol Chem, 277, 36955-36961.  
12297048 D.E.Kang, S.Soriano, X.Xia, C.G.Eberhart, B.De Strooper, H.Zheng, and E.H.Koo (2002).
Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis.
  Cell, 110, 751-762.  
12029080 D.Gong, Z.Gong, Y.Guo, X.Chen, and J.K.Zhu (2002).
Biochemical and functional characterization of PKS11, a novel Arabidopsis protein kinase.
  J Biol Chem, 277, 28340-28350.  
11861647 D.M.Ferkey, and D.Kimelman (2002).
Glycogen synthase kinase-3 beta mutagenesis identifies a common binding domain for GBP and Axin.
  J Biol Chem, 277, 16147-16152.  
12419241 D.P.Brazil, J.Park, and B.A.Hemmings (2002).
PKB binding proteins. Getting in on the Akt.
  Cell, 111, 293-303.  
12121643 E.J.Goldsmith, and C.I.Chang (2002).
Another twist in helix C and a missing pocket.
  Structure, 10, 888-889.  
11877389 E.Smith, G.A.Coetzee, and B.Frenkel (2002).
Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta.
  J Biol Chem, 277, 18191-18197.  
12065620 F.Mukai, K.Ishiguro, Y.Sano, and S.C.Fujita (2002).
Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3beta.
  J Neurochem, 81, 1073-1083.  
11934263 H.Brantjes, N.Barker, J.van Es, and H.Clevers (2002).
TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
  Biol Chem, 383, 255-261.  
11879773 H.Eldar-Finkelman (2002).
Glycogen synthase kinase 3: an emerging therapeutic target.
  Trends Mol Med, 8, 126-132.  
12167628 H.S.Kim, C.Skurk, S.R.Thomas, A.Bialik, T.Suhara, Y.Kureishi, M.Birnbaum, J.F.Keaney, and K.Walsh (2002).
Regulation of angiogenesis by glycogen synthase kinase-3beta.
  J Biol Chem, 277, 41888-41896.  
12358132 H.Takano, Y.Zou, H.Akazawa, H.Toko, M.Mizukami, H.Hasegawa, M.Asakawa, T.Nagai, and I.Komuro (2002).
Inhibitory molecules in signal transduction pathways of cardiac hypertrophy.
  Hypertens Res, 25, 491-498.  
12142282 M.A.Pufall, and B.J.Graves (2002).
Autoinhibitory domains: modular effectors of cellular regulation.
  Annu Rev Cell Dev Biol, 18, 421-462.  
11756553 M.Pap, and G.M.Cooper (2002).
Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
  Mol Cell Biol, 22, 578-586.  
12387679 O.Kaidanovich, and H.Eldar-Finkelman (2002).
The role of glycogen synthase kinase-3 in insulin resistance and type 2 diabetes.
  Expert Opin Ther Targets, 6, 555-561.  
12000790 S.Amit, A.Hatzubai, Y.Birman, J.S.Andersen, E.Ben-Shushan, M.Mann, Y.Ben-Neriah, and I.Alkalay (2002).
Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
  Genes Dev, 16, 1066-1076.  
11805297 S.C.h.Papasozomenos, and A.Shanavas (2002).
Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3 beta but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer's disease.
  Proc Natl Acad Sci U S A, 99, 1140-1145.  
11927557 S.Yanagawa, Y.Matsuda, J.S.Lee, H.Matsubayashi, S.Sese, T.Kadowaki, and A.Ishimoto (2002).
Casein kinase I phosphorylates the Armadillo protein and induces its degradation in Drosophila.
  EMBO J, 21, 1733-1742.  
11967263 T.Hagen, E.Di Daniel, A.A.Culbert, and A.D.Reith (2002).
Expression and characterization of GSK-3 mutants and their effect on beta-catenin phosphorylation in intact cells.
  J Biol Chem, 277, 23330-23335.  
12421363 W.H.Stoothoff, C.D.Bailey, K.Mi, S.C.Lin, and G.V.Johnson (2002).
Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
  J Neurochem, 83, 904-913.  
11812770 W.Sun, H.Y.Qureshi, P.W.Cafferty, K.Sobue, A.Agarwal-Mawal, K.D.Neufield, and H.K.Paudel (2002).
Glycogen synthase kinase-3beta is complexed with tau protein in brain microtubules.
  J Biol Chem, 277, 11933-11940.  
12000743 Z.Wang, J.Frederick, and M.J.Garabedian (2002).
Deciphering the phosphorylation "code" of the glucocorticoid receptor in vivo.
  J Biol Chem, 277, 26573-26580.  
11439177 A.J.Harwood (2001).
Regulation of GSK-3: a cellular multiprocessor.
  Cell, 105, 821-824.  
11590039 D.Gurwitz, and H.Eldar-Finkelman (2001).
Monitor and Molecules.
  Drug Discov Today, 6, 1072-1073.  
11589691 P.Cohen (2001).
The role of protein phosphorylation in human health and disease. The Sir Hans Krebs Medal Lecture.
  Eur J Biochem, 268, 5001-5010.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.

 

spacer

spacer